ebook_ADHD2019_spanish

grefe, Kohlhammer, CIP Medien, Oxford University Press. El King’s College London recibió regalías por el trabajo dirigido por Philip Asherson: consejería para Shire, Eli-Lilly, Novartis, Lundbeck and Medice; han recibido premios educacionales y por investigación de Shire, Eli-Lilly, Novartis, Vifor Pharma, GW Pharma, and QbTech; speaker en eventos patrocinados por Shire, Eli-Lilly, Janssen-Ci- lag, Medice and Novartis. REFERENCIAS BIBLIOGRÁFICAS 1. Polanczyk G, Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942-8. 2. Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, et al. Attention- -deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015;1:15020. 3. Fayyad J, Sampson NA, Hwang I, Adamowski T, Aguilar-Gaxiola S, Al-Hamzawi A, et al. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord. 2017;9(1):47-65. 4. Asherson P, Buitelaar J, Faraone SV, Rohde LA. Adult attention-deficit hyperactivity disorder: key con- ceptual issues. Lancet Psychiatry. 2016;3(6):568-78. 5. World Health Organization. ICD-11: international classification of diseases 11th revision: the global stan- dard for diagnostic health information. Geneva: WHO, 2018. Disponível em: https://icd.who.int/ . Acess: 23 nov. 2018. 6. American Psychiatry Association. DSM5: diagnostic and statistical manual of mental disorders. 5th ed. Washington: APA, 2013. 7. Rohde LA, Kieling C, Salum GA. Current diagnostic criteria: DSM, ICD and future perspectives. In: Banascheswki T, Coghill D, Zuddas A. Oxford textbook of attention deficit hyperactivity disorder. Oxford: Oxford University Press, 2018. 8. American Psychiatry Association. DSM-III: diagnostic and statistical manual of mental disorders. 3rd ed. Washington: APA, 1985. 9. American Psychiatry Association. DSM-IV-TR: diagnostic and statistical manual of mental disorders. 4th ed. Washington: APA, 2011. 10. Coghill D, Asherson P, Faraone SV, Rohde LA. The age of onset of ADHD. In: Girolamo G, McGorry PD, Sartorius N, editors. The age of onset of mental disorders: etiopathogenetic and treatment. [S. l.]: Sprin- ger International Publishing, 2018. 11. Caye A, Sibley MH, Swanson JM, Rohde LA. Late-onset ADHD: understanding the evidence and buil- ding theoretical frameworks. Curr Psychiatry Rep. 2017;19(12):106. 12. Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9(3):490-9. 13. Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, et al. Validity of DSM-IV at- tention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol. 2012;121(4):991- 1010. 14. Dias TG, Kieling C, Graeff-Martins AS, Moriyama TS, Rohde LA, Polanczyk GV. Developments and challenges in the diagnosis and treatment of ADHD. Braz J Psychiatr. 2013;35 Suppl 1:S40-50. 68 Rohde, Buitelaar, Gerlach & Faraone (editores)